Roy D. Baynes - 15 Nov 2024 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
Director
Signature
/s/ Tami Chen, Attorney-in-Fact
Issuer symbol
NTRA
Transactions as of
15 Nov 2024
Transactions value $
-$4,565,388
Form type
4
Filing time
15 Nov 2024, 21:50:08 UTC
Previous filing
29 Oct 2024
Next filing
23 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise $502,260 +22,000 +139% $22.83 37,807 15 Nov 2024 Direct
transaction NTRA Common Stock Options Exercise $371,916 +15,230 +40% $24.42 53,037 15 Nov 2024 Direct
transaction NTRA Common Stock Sale -$793,419 -5,500 -10% $144.26 47,537 15 Nov 2024 Direct F1, F2
transaction NTRA Common Stock Sale -$2,381,996 -16,404 -35% $145.21 31,133 15 Nov 2024 Direct F1, F3
transaction NTRA Common Stock Sale -$258,871 -1,770 -5.7% $146.26 29,363 15 Nov 2024 Direct F1, F4
transaction NTRA Common Stock Sale -$1,394,619 -9,467 -32% $147.31 19,896 15 Nov 2024 Direct F1, F5
transaction NTRA Common Stock Sale -$313,249 -2,106 -11% $148.74 17,790 15 Nov 2024 Direct F1, F6
transaction NTRA Common Stock Sale -$297,407 -1,983 -11% $149.98 15,807 15 Nov 2024 Direct F1, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Stock Option (right to buy) Options Exercise $0 -22,000 -100% $0 0 15 Nov 2024 Common Stock 22,000 $22.83 Direct F8
transaction NTRA Stock Option (right to buy) Options Exercise $0 -15,230 -100% $0 0 15 Nov 2024 Common Stock 15,230 $24.42 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2024.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.81 to $144.70 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.85 to $145.81 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.87 to $146.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.067 to $147.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.35 to $149.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.87 to $150.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The option shares are fully exercisable.
F9 The option shares are fully exercisable.